Immunic Stock Technical Analysis
| IMUX Stock | USD 0.62 0.03 5.08% |
As of the 10th of February, Immunic retains the Risk Adjusted Performance of (0.02), market risk adjusted performance of (0.15), and Standard Deviation of 4.56. Immunic technical analysis makes it possible for you to employ historical prices and volume momentum with the intention to determine a pattern that calculates the direction of the firm's future prices.
Immunic Momentum Analysis
Momentum indicators are widely used technical indicators which help to measure the pace at which the price of specific equity, such as Immunic, fluctuates. Many momentum indicators also complement each other and can be helpful when the market is rising or falling as compared to ImmunicImmunic's Momentum analyses are specifically helpful, as they help investors time the market using mark points where the market can reverse. The reversal spots are usually identified through divergence between price movement and momentum.Immunic Analyst Consensus
| Target Price | Consensus | # of Analysts | |
| 5.38 | Strong Buy | 7 | Odds |
Most Immunic analysts issue ratings four times a year, at intervals of three months. Ratings are usually accompanied by a target price to helps potential investors understand Immunic stock's fair price compared to its market value. Analysts arrive at stock ratings after researching public financial statements of Immunic, talking to its executives and customers, or listening to Immunic conference calls.
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Immunic. Market participants price Immunic higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Immunic assessment requires weighing all these inputs, though not all factors influence outcomes equally.
Immunic's market price often diverges from its book value, the accounting figure shown on Immunic's balance sheet. Smart investors calculate Immunic's intrinsic value - its true economic worth - which may differ significantly from both market price and book value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Since Immunic's trading price responds to investor sentiment, macroeconomic conditions, and market psychology, it can swing far from fundamental value.
Please note, there is a significant difference between Immunic's value and its price as these two are different measures arrived at by different means. Investors typically determine if Immunic is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. However, Immunic's price is the amount at which it trades on the open market and represents the number that a seller and buyer find agreeable to each party.
Immunic 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Immunic's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Immunic.
| 11/12/2025 |
| 02/10/2026 |
If you would invest 0.00 in Immunic on November 12, 2025 and sell it all today you would earn a total of 0.00 from holding Immunic or generate 0.0% return on investment in Immunic over 90 days. Immunic is related to or competes with Pmv Pharmaceuticals, Relmada Therapeutics, Acrivon Therapeutics, Lite Strategy, Vaxart, Tscan Therapeutics, and Biomea Fusion. Immunic, Inc., a clinical-stage biopharmaceutical company, develops a pipeline of selective oral immunology therapies fo... More
Immunic Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Immunic's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Immunic upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.06) | |||
| Maximum Drawdown | 21.44 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 9.43 |
Immunic Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Immunic's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Immunic's standard deviation. In reality, there are many statistical measures that can use Immunic historical prices to predict the future Immunic's volatility.| Risk Adjusted Performance | (0.02) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.16) |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Immunic's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Immunic February 10, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 3.59 | |||
| Coefficient Of Variation | (2,444) | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.77 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 21.44 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 9.43 | |||
| Skewness | 0.3912 | |||
| Kurtosis | 0.048 |
Immunic Backtested Returns
Immunic holds Efficiency (Sharpe) Ratio of -0.0529, which attests that the entity had a -0.0529 % return per unit of risk over the last 3 months. Immunic exposes twenty-three different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check out Immunic's Standard Deviation of 4.56, market risk adjusted performance of (0.15), and Risk Adjusted Performance of (0.02) to validate the risk estimate we provide. The company retains a Market Volatility (i.e., Beta) of 1.26, which attests to a somewhat significant risk relative to the market. As the market goes up, the company is expected to outperform it. However, if the market returns are negative, Immunic will likely underperform. At this point, Immunic has a negative expected return of -0.24%. Please make sure to check out Immunic's jensen alpha, skewness, as well as the relationship between the Skewness and day typical price , to decide if Immunic performance from the past will be repeated at some point in the near future.
Auto-correlation | -0.23 |
Weak reverse predictability
Immunic has weak reverse predictability. Overlapping area represents the amount of predictability between Immunic time series from 12th of November 2025 to 27th of December 2025 and 27th of December 2025 to 10th of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Immunic price movement. The serial correlation of -0.23 indicates that over 23.0% of current Immunic price fluctuation can be explain by its past prices.
| Correlation Coefficient | -0.23 | |
| Spearman Rank Test | -0.16 | |
| Residual Average | 0.0 | |
| Price Variance | 0.0 |
Immunic technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.
Immunic Technical Analysis
The output start index for this execution was one with a total number of output elements of sixty. The Normalized Average True Range is used to analyze tradable apportunities for Immunic across different markets.
About Immunic Technical Analysis
The technical analysis module can be used to analyzes prices, returns, volume, basic money flow, and other market information and help investors to determine the real value of Immunic on a daily or weekly bases. We use both bottom-up as well as top-down valuation methodologies to arrive at the intrinsic value of Immunic based on its technical analysis. In general, a bottom-up approach, as applied to this company, focuses on Immunic price pattern first instead of the macroeconomic environment surrounding Immunic. By analyzing Immunic's financials, daily price indicators, and related drivers such as dividends, momentum ratios, and various types of growth rates, we attempt to find the most accurate representation of Immunic's intrinsic value. As compared to a bottom-up approach, our top-down model examines the macroeconomic factors that affect the industry/economy before zooming in to Immunic specific price patterns or momentum indicators. Please read more on our technical analysis page.
| 2010 | 2025 | 2026 (projected) | Dividend Yield | 0.007985 | 0.007187 | 0.006388 | Price To Sales Ratio | 21.6K | 19.5K | 17.3K |
Immunic February 10, 2026 Technical Indicators
Most technical analysis of Immunic help investors determine whether a current trend will continue and, if not, when it will shift. We provide a combination of tools to recognize potential entry and exit points for Immunic from various momentum indicators to cycle indicators. When you analyze Immunic charts, please remember that the event formation may indicate an entry point for a short seller, and look at different other indicators across different periods to confirm that a breakdown or reversion is likely to occur.
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | (0.02) | |||
| Market Risk Adjusted Performance | (0.15) | |||
| Mean Deviation | 3.59 | |||
| Coefficient Of Variation | (2,444) | |||
| Standard Deviation | 4.56 | |||
| Variance | 20.77 | |||
| Information Ratio | (0.06) | |||
| Jensen Alpha | (0.31) | |||
| Total Risk Alpha | (0.70) | |||
| Treynor Ratio | (0.16) | |||
| Maximum Drawdown | 21.44 | |||
| Value At Risk | (6.58) | |||
| Potential Upside | 9.43 | |||
| Skewness | 0.3912 | |||
| Kurtosis | 0.048 |
Immunic February 10, 2026 Daily Trend Indicators
Traders often use several different daily volumes and price technical indicators to supplement a more traditional technical analysis when analyzing securities such as Immunic stock. With literally thousands of different options, investors must choose the best indicators for them and familiarize themselves with how they work. We suggest combining traditional momentum indicators with more near-term forms of technical analysis such as Accumulation Distribution or Daily Balance Of Power. With their quantitative nature, daily value technical indicators can also be incorporated into your automated trading systems.
| Accumulation Distribution | 0.06 | ||
| Daily Balance Of Power | 0.75 | ||
| Rate Of Daily Change | 1.05 | ||
| Day Median Price | 0.60 | ||
| Day Typical Price | 0.61 | ||
| Price Action Indicator | 0.04 | ||
| Market Facilitation Index | 0.04 |
Additional Tools for Immunic Stock Analysis
When running Immunic's price analysis, check to measure Immunic's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Immunic is operating at the current time. Most of Immunic's value examination focuses on studying past and present price action to predict the probability of Immunic's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Immunic's price. Additionally, you may evaluate how the addition of Immunic to your portfolios can decrease your overall portfolio volatility.